Breast Densitometry & Breast Cancer Risk Assessment - International Workshop
June 6th and 7th, 2013
We invite you to attend the 6th International Breast Densitometry and Breast Cancer Risk Assessment Workshop. A high amount of dense breast tissue has been shown to be one of the strongest risk factors for breast cancer, although the specific reason(s) for this is not known. Recent legislation in several states including California require reporting of breast density to women with dense breasts undergoing mammography. Ideally, prior to enacting legislation, there would be guidelines on how best to measure breast density, what risk model to use that includes breast density to report breast cancer risk, as well as a standardized form to communicate this information. Research is ongoing to understand how different technologies that measure breast density relate to both breast cancer detection and breast cancer risk.
Each workshop has had different objectives around the core workshop theme of breast density and cancer risk. This year, our objectives are:
- Understand state laws requiring reporting of breast density and provide expert feedback to policymakers regarding implementing reporting breast density to women.
- Inform participants on the advances in quantifying breast density and non-density image features and how it relates to breast cancer risk.
- Examine the biology and genetics of breast density, how it relates to breast cancer risk, and how this knowledge may lead to better measurement of breast density.
- Explore women’s knowledge of breast density and communication of breast density and breast cancer risk in clinical practice.
Travel Scholarships for Advocates: Breast cancer advocates that submit abstracts will be considered for a travel scholarship.
We hope to see you soon!
Steve Cummings, MD - California Pacific Medical Center
Karla Kerlikowski, MD - UCSF Medicine
John Shepherd, PhD - UCSF Radiology and Biomedical Imaging
Abstract Submission CLOSED
Submit Abstracts by Friday April 26, 2013
Abstracts should not exceed 500 words, and should be submitted via email to email@example.com.
The word ABSTRACT should be included in the subject heading of the email. Note that the abstracts need not conform to any specific structure.
Please include the following information along with your abstract:
The International Workshop on Breast Densitometry and Breast Cancer Risk Assessment gratefully acknowledge support from the following institutions:
- American Cancer Society
- California Breast Cancer Research Program
- Daniel and Phyllis Da Costa Foundation of the CPMC Foundation
- Hologic, Inc.
- Matakina International Limited
- Sutter Health at California Pacific Medical Center
- UCSF Department of Epidemiology & Biostatistics
- UCSF Department of Medicine
- UCSF Department of Radiology and Bio Medical Imaging
- U-Systems - A GE Healthcare Company